InvestSMART

Acrux Limited (ASX:ACR)

ALERT: Price-sensitive ASX Announcement for ACR
Current share price for ACR : $0.011 0 (0%)+
Announcement
Release
11 May 2026 10:58AM
Price at Release
$0.011
Full Release
download
Summary
Acrux Limited has raised $1.6 million via a Share Placement to institutional and professional investors at 0.95 cents per share, offering one unlisted attaching option for every two shares, subject to approval. The placement, scaled back from $2.6 million to manage commitments, will fund the development of female testosterone treatments and a co-development agreement. The offer represents a significant discount to market prices, reflecting strong shareholder support and interest in ongoing clinical trials. The process is managed by Alpine Capital, with CEO John Warmbrunn expressing appreciation for the investor confidence shown.
Key Points
  • Acrux Limited raises $1.6 million through a Share Placement.
  • The share placement issue price is 0.95 cents per share.
  • Commitments totaled $2.6 million, but the placement was scaled back by $1.0 million.
  • One unlisted attaching option for every 2 shares subscribed for is offered, subject to shareholder approval.
  • Attaching Options have an exercise price of $0.018 and a 3-year term.
  • Proceeds will fund the development of female testosterone and support a co-development agreement.
  • The placement offer price is a 13.6% discount to the last traded price and a 16.8% discount to the 5 Day VWAP.
  • Acrux CEO expresses gratitude for shareholder support and interest in clinical trials.
  • Placement is managed by Alpine Capital as Lead Managers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.